Security key
G52441105
KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS)
CUSIP: G52441105
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 56,150,806
- Total 13F value
- $1,489,190,179
- Share change
- +5,188,231
- SEC-reported price per share
- $26.52
- Number of holders
- 108
- Value change
- +$139,802,244
- Number of buys
- 82
- Number of sells
- 17
- Shares outstanding
- 58,516,314
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q4 2025
Institutions
108
Top holders
10
KMTS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC filings
KESTRA MEDICAL TECHNOLOGIES, LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G52441105
Recent filing periods:
Ownership snapshot
Top reported holders of KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bain Charger Holdings, L.P.
Disclosed value leader
BAIN CAPITAL INVESTORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
3/4/5
Lead comparable stake: 43%
13D/G row: Bain Charger Holdings, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Bain Charger Holdings, L.P. leads the comparable SEC ownership view at 43%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Bain Charger Holdings, L.P.
43%
FMR LLC
10%
Endeavour Medtech Growth II LP
4.2%
Jeffrey Lawrence Schwartz
46%
Mary Kay Ladone
0.04%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bain Charger Holdings, L.P. |
13D/G
|
43%
|
$554,798,330
25,172,338 shares
|
-$40,705,389 | 31 Dec 2025 |
| FMR LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$125,404,995
5,277,988 shares
|
— | 30 Sep 2025 |
| Endeavour Medtech Growth II LP |
13D/G
|
4.2%
|
$53,974,682
2,448,942 shares
|
-$4,362,972 | 31 Dec 2025 |
| Jeffrey Lawrence Schwartz |
3/4/5
Director, 10%+ Owner
|
46%
|
$429,508,829
27,030,134 shares
|
— | 04 Sep 2025 |
| Mary Kay Ladone |
3/4/5
Director
|
0.04%
|
$379,818
23,903 shares
|
— | 04 Sep 2025 |
| Timothy P. Moran |
3/4/5
Chief Business Officer
|
0.03%
|
$538,990
19,557 shares
|
— | 03 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
108
Shares
56,150,806
Rows available
108
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
79
Q4 2025 holders
108
Holder diff
29
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend